DBT
BBH icon

Dubuque Bank & Trust’s VanEck Biotech ETF BBH Stock Holding History

Dubuque Bank & Trust’s Portfolio BBH Stock Details BBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-250
Closed -$34K – 657
2018
Q3 		$34K Hold
250
– – 0.01% 301
2018
Q2 		$30K Hold
250
– – ﹤0.01% 362
2018
Q1 		$30K Buy
+250
New +$31.4K ﹤0.01% 393

Other funds holding BBH

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
MCM
Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
SFS
Strategic Financial Services Utica, New York $2.1B AUM 19.14% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
MJRIC
Mogy Joel R Investment Counsel Beverly Hills, California $1.75B AUM 17.81% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Dubuque Bank & Trust's BBH Position: Q4 2018 in Review

Dubuque Bank & Trust sold out of VanEck Biotech ETF (BBH) in Q4 2018, closing a stake of 250 shares — an estimated $34K sold.

Dubuque Bank & Trust first reported a position in BBH in Q1 2018 and held it in 3 quarters. The position peaked at $34K in Q3 2018. 84 funds tracked by Wall St. Rank hold BBH as of Q4 2018.

  • Dubuque Bank & Trust reported no remaining VanEck Biotech ETF position as of Q4 2018 after selling out during the quarter.
  • Dubuque Bank & Trust sold 250 VanEck Biotech ETF shares in Q4 2018, an estimated $34K.
  • Dubuque Bank & Trust first reported a position in VanEck Biotech ETF in Q1 2018 and held it in 3 quarters.
  • Dubuque Bank & Trust's VanEck Biotech ETF position peaked at $34K in Q3 2018.
  • 84 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q4 2018.

Based on Dubuque Bank & Trust's 13F filing for Q4 2018, filed 15 Jan 2019.